For manufacturers based outside the EU, appointing an Authorised Representative for medical devices is an important part of accessing the European market. But the role involves much more than providing a European contact point. Under the MDR and IVDR, an Authorised Representative has defined regulatory responsibilities covering documentation, conformity assessment, EUDAMED, communication with authorities, and other compliance activities.
As medical devices become increasingly software-driven and regulatory requirements continue to evolve, manufacturers also need an approach that can keep up with frequent documentation and product changes. This is where a Digital Authorised Representative can provide a different model – combining regulatory expertise with a secure digital environment for managing compliance activities.
What Is an Authorised Representative for Medical Devices?
An Authorised Representative is an EU-established legal entity appointed by a manufacturer located outside the EU through a written mandate. The representative acts on the manufacturer’s behalf for specified regulatory obligations under the MDR or IVDR.
The role carries significant responsibilities. Among other tasks, an Authorised Representative must verify that the EU Declaration of Conformity and technical documentation have been drawn up and, where applicable, that the appropriate conformity assessment procedure has been carried out. The representative must also keep relevant documentation available for competent authorities and verify that the manufacturer has fulfilled applicable EUDAMED registration obligations.
The relationship therefore depends on more than simply naming a representative on a device label. The manufacturer needs to provide the representative with the documentation required to perform these duties, while the representative needs processes that allow regulatory information to be reviewed, maintained and made available when required.
Why Traditional Authorised Representation Can Become Difficult to Manage
Traditional AR workflows often depend heavily on email, shared folders and manual document exchanges. That approach can become difficult to manage as a manufacturer’s portfolio grows.
Technical documentation changes. Labels are updated. New UDI-DIs are introduced. Devices move through different regulatory stages. Post-market information needs to be reviewed. Economic operators may also need access to specific documentation.
When these activities are managed across disconnected channels, maintaining a clear record of who reviewed what, when it was approved and which version was used can become increasingly difficult.
This is particularly relevant for software and AI-enabled medical devices. Frequent product updates can create a greater need for agile compliance oversight, making a static approach to Authorised Representation less suited to the pace of change. MedQAIR specifically positions its Digital AR workflow for software and AI-enabled devices where frequent updates require ongoing oversight.
What Is a Digital Authorised Representative?
A Digital Authorised Representative combines regulatory expertise with a secure, cloud-based compliance platform.
Instead of relying primarily on manual document exchange, a Digital AR provides a structured environment where manufacturers can securely upload technical documentation and labelling materials, initiate verification workflows, manage approvals and connect relevant activities with EUDAMED.
For MedQAIR, the Digital AR model is built around MDIS, the company’s medical device compliance platform.
Manufacturers can use the platform to initiate verification flows for Basic UDI-DIs and UDI-DIs, while UDI/Device registrations in EUDAMED can be automated through the same system.
The objective is not to replace regulatory expertise with software. Rather, the digital platform provides the infrastructure through which regulatory work can be performed faster, more transparently and with greater traceability.
How MedQAIR’s Digital AR Works
Once the Digital Authorised Representative agreement is signed, the manufacturer can upload its documentation to the platform. MedQAIR’s experts review the documentation and communicate approval through the software, allowing devices to move through the process efficiently.
The review approach is also structured according to device type and the applicable Article 11 requirements. For example, MedQAIR describes:
- Class I devices: limited review of the Declaration of Conformity and key changes.
- Class IIa / IIb devices: review against Article 11 requirements, including the presence of the Declaration of Conformity and technical documentation, within 72 hours.
- Class III / IIb implantable devices: review focused on Article 11 requirements and changes that could affect safety or performance.
This structured approach is designed to support faster review without losing sight of the regulatory responsibilities of the Authorised Representative.
Digital Change Management for Medical Devices
One of the biggest advantages of a Digital AR becomes apparent after the initial approval.
Medical devices do not remain static. Manufacturers may update technical documentation, modify labelling, introduce new UDI-DIs or make changes that require regulatory review. A Digital Authorised Representative can provide a more structured way to manage these changes.
MedQAIR conducts a yearly compliance review in which it digitally reviews the manufacturer’s change-management processes and post-market surveillance data. The review can also be extended to an official internal audit that the manufacturer can use within its quality management system.
This creates a continuous oversight model rather than treating Authorised Representation as a one-time pre-market activity.
Connecting UDI and EUDAMED With Authorised Representation
UDI and EUDAMED activities are another important part of modern medical device compliance. Under the MDR and IVDR, the Authorised Representative has responsibilities relating to its own registration in EUDAMED and to verifying that the manufacturer has fulfilled applicable registration obligations. However, the manufacturer’s own registration obligations cannot simply be delegated to the representative.
A connected digital workflow can make these activities easier to coordinate.
MedQAIR’s platform allows manufacturers to initiate verification flows for Basic UDI-DIs and UDI-DIs and automate UDI/Device registrations in EUDAMED through the same system used for the Digital AR service.
This can reduce repetitive manual checks while keeping the relevant information and approval history connected.
Traceability and Secure Documentation
A strong medical device Authorised Representative workflow also needs to protect sensitive technical information.
MedQAIR’s Digital AR service uses MDIS to centralise technical documentation, CE certificates and localised labelling materials within a controlled device workspace. Manufacturers can securely share relevant documentation with importers, distributors and other authorised stakeholders while controlling which information each party can access.
The platform also records verification and approval activities, creating an auditable history of compliance activities. MedQAIR states that contracts, verification steps and mandatory documentation are securely stored in one location.
Security is further supported by MedQAIR’s implementation of ISO/IEC 27001 to support technical and organisational measures for documentation security, confidentiality, data integrity and platform availability.
Digital Authorised Representation Across Europe
The regulatory needs of manufacturers do not always stop at the EU.
MedQAIR’s Digital AR service currently covers the European Union, the United Kingdom and Switzerland, with plans to expand through cooperation with local compliance partners and in-country representatives.
For manufacturers managing multiple markets, having a connected regulatory workflow can help reduce fragmentation between different compliance activities and stakeholders.
Why Choose a Digital Authorised Representative?
The value of a Digital Authorised Representative is ultimately not about adding another software layer to the regulatory process. It is about making the relationship between the manufacturer and its representative more transparent, structured and responsive.
A digital approach can help manufacturers:
- securely share technical documentation and labelling;
- manage verification and approval workflows;
- maintain traceable compliance records;
- coordinate UDI and EUDAMED activities;
- provide controlled access to importers and distributors;
- manage regulatory changes more efficiently;
- maintain ongoing oversight of compliance and post-market activities; and
- support the needs of software and AI-enabled medical devices with frequent updates.
The same controlled document model can also support electronic IFU publication, with per-device access, version control and audit logging.
For manufacturers, this means the Authorised Representative relationship can become part of the wider compliance workflow rather than a separate administrative process.
A Digital-First Future for Authorised Representation
The role of the EU Authorised Representative is already defined by substantial regulatory responsibilities. As medical device portfolios become more complex and software-based products evolve more frequently, the way those responsibilities are managed also needs to evolve.
A Digital Authorised Representative provides a way to combine regulatory expertise with secure documentation management, traceable workflows, UDI management and EUDAMED connectivity.
For MedQAIR, the goal is to make Authorised Representation fast, continuous, secure and transparent, while keeping regulatory expertise at the centre of the process.
If your organisation is looking for an Authorised Representative for medical devices that combines regulatory support with a digital compliance workflow, explore MedQAIR’s Digital AR to see how the approach works.
